NFL Biosciences: CESTO II Results Confirm NFL-101 Effectiveness
- NFL biosciences, a biopharmaceutical company developing botanical drugs for addiction treatment, announced the results of the immunological analysis of its Phase 2 CESTO II study.
- A secondary objective of the CESTO II study was to explore a possible association between the induction of anti-tobacco IgG and continuous smoking abstinence.
- Continuous abstinence was confirmed using the urinary cotinine biomarker.
NFL Biosciences presents Immunological Analysis Results of Phase 2 CESTO II Study
Table of Contents
- NFL Biosciences presents Immunological Analysis Results of Phase 2 CESTO II Study
- NFL Biosciences CESTO II Study: A Q&A on Tobacco Addiction Treatment
- What is NFL Biosciences?
- What is the CESTO II Study?
- What are the Key findings from the CESTO II study?
- What is the Meaning of Anti-Tobacco IgG?
- How Does NFL-101 Work?
- What is Continuous Abstinence, and Why is it Vital?
- How does the CESTO II study differ from previous studies?
- What Are the Next Steps for NFL Biosciences?
- Summary of findings
Posted on March 24, 2025
NFL biosciences, a biopharmaceutical company developing botanical drugs for addiction treatment, announced the results of the immunological analysis of its Phase 2 CESTO II study. The study confirms the effectiveness of NFL-101 as a treatment against tobacco addiction.
A secondary objective of the CESTO II study was to explore a possible association between the induction of anti-tobacco IgG and continuous smoking abstinence. This was intended to provide additional biological evidence to support behavioral observations based on abstinence measures.
Continuous abstinence was confirmed using the urinary cotinine biomarker. Researchers found that an increase in IgG serves as a distinct immunological marker, reflecting the specific biological response triggered by the treatment. Immunogenicity tests, conducted at several intervals, confirmed a dose-dependent increase in anti-tobacco IgG levels. This effect was not observed in the placebo group, indicating that NFL-101 has an intrinsic immunogenic effect.
By comparing anti-tobacco IgG rates over time between continuously abstinent subjects and non-abstinent subjects,statistically meaningful differences (p less than 0.05) were observed. Higher IgG levels were found in continuously abstinent individuals, irrespective of the dose of NFL-101 received. These results suggest an association between the increase in anti-tobacco IgG following the administration of NFL-101 and the maintenance of continuous abstinence.
This association strengthens the evidence that the superior efficiency observed in terms of continuous abstinence is attributable to the administration of NFL-101. These results mark the completion of the analysis of CESTO II study data and have been integrated into the publication project.
NFL Biosciences CESTO II Study: A Q&A on Tobacco Addiction Treatment
published on March 24, 2025
NFL Biosciences, a biopharmaceutical company, recently announced compelling results from the immunological analysis of its Phase 2 CESTO II study. This article provides a extensive Q&A too break down the key findings and their implications for tobacco addiction treatment.
What is NFL Biosciences?
NFL Biosciences is a biopharmaceutical company focused on developing botanical drugs for addiction treatment. Their research aims to provide innovative solutions for those struggling with substance abuse.
What is the CESTO II Study?
The CESTO II study is a Phase 2 clinical trial conducted by NFL Biosciences. It focused on evaluating the efficacy of NFL-101, a botanical drug, as a treatment for tobacco addiction.
What are the Key findings from the CESTO II study?
The immunological analysis of the CESTO II study confirms the effectiveness of NFL-101 in treating tobacco addiction. Key findings include:
- NFL-101 was associated with the induction of anti-tobacco IgG (a type of antibody).
- A dose-dependent increase in anti-tobacco IgG levels was observed in the treatment group.
- higher IgG levels were found in continuously abstinent individuals, irrespective of the dose of NFL-101 received.
- A statistically meaningful association was observed between increased anti-tobacco IgG and continuous abstinence (p < 0.05).
What is the Meaning of Anti-Tobacco IgG?
The study found that an increase in anti-tobacco IgG serves as a distinct immunological marker. This indicates that the treatment triggers a specific biological response in the body, offering further biological evidence supporting the effectiveness of NFL-101.
How Does NFL-101 Work?
the research indicates that NFL-101 has an intrinsic immunogenic effect. This means that it triggers the body’s immune system to produce antibodies (IgG) against tobacco, which could perhaps contribute to the reduction of cravings or withdrawal symptoms, though the specific mechanism of action is not fully detailed within the provided text.
What is Continuous Abstinence, and Why is it Vital?
Continuous abstinence refers to sustained cessation of smoking over a period of time. It is a critical measure of treatment success in tobacco addiction studies. In the CESTO II study, continuous abstinence was confirmed using the urinary cotinine biomarker, which is a reliable indicator of tobacco use.
How does the CESTO II study differ from previous studies?
In the CESTO II study, researchers explored a possible association between the induction of anti-tobacco IgG and continuous smoking abstinence. This provided new biological evidence to support behavioral observations.
What Are the Next Steps for NFL Biosciences?
The results from the CESTO II study’s immunological analysis have been integrated into a publication project. Further details about the next steps for NFL Biosciences are not available in the provided text.
Summary of findings
The following table summarizes the key findings from the CESTO II study:
| Aspect | Finding |
|---|---|
| Primary Goal | Evaluate effectiveness of NFL-101 |
| Immunological Marker | Increase in anti-tobacco IgG |
| Association | Higher IgG levels linked to continuous abstinence |
| Clinical Significance | Confirms NFL-101’s efficacy in treating tobacco addiction |
© 2025. All rights reserved.